Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model.

Choi YH, Chapman R, Gay N, Jit M.

Vaccine. 2012 May 14;30(23):3383-8. doi: 10.1016/j.vaccine.2012.03.065. Epub 2012 Apr 3.

PMID:
22480925
[PubMed - indexed for MEDLINE]
2.
3.

Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.

McCormack PL, Joura EA.

Drugs. 2010 Dec 24;70(18):2449-74. doi: 10.2165/11204920-000000000-00000. Review.

PMID:
21142263
[PubMed - indexed for MEDLINE]
4.

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.

Jenkins D.

Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Review.

PMID:
18653221
[PubMed - indexed for MEDLINE]
5.
6.

Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.

McCormack PL, Joura EA.

BioDrugs. 2011 Oct 1;25(5):339-43. doi: 10.2165/11205060-000000000-00000. Review.

PMID:
21942919
[PubMed - indexed for MEDLINE]
7.

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Dunne EF, Datta SD, E Markowitz L.

Cancer. 2008 Nov 15;113(10 Suppl):2995-3003. doi: 10.1002/cncr.23763. Review.

PMID:
18980283
[PubMed - indexed for MEDLINE]
Free Article
8.

Long-term efficacy of human papillomavirus vaccination.

Ault KA.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S27-30. Review.

PMID:
17938016
[PubMed - indexed for MEDLINE]
9.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
[PubMed - indexed for MEDLINE]
10.

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Syrjänen KJ.

Scand J Infect Dis Suppl. 2009;107:3-32. doi: 10.1080/00365540902887730. Review.

PMID:
19408160
[PubMed - indexed for MEDLINE]
11.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

PMID:
17671238
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
[PubMed - indexed for MEDLINE]
13.

What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.

Lynge E, Antilla A, Arbyn M, Segnan N, Ronco G.

Eur J Cancer. 2009 Oct;45(15):2714-21. doi: 10.1016/j.ejca.2009.07.024. Epub 2009 Aug 18. Review.

PMID:
19695870
[PubMed - indexed for MEDLINE]
14.

Human papillomavirus vaccines: an update for gynecologists.

Ault KA.

Clin Obstet Gynecol. 2008 Sep;51(3):527-32. doi: 10.1097/GRF.0b013e31818092df. Review.

PMID:
18677145
[PubMed - indexed for MEDLINE]
15.

Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines.

Romanowski B.

Hum Vaccin. 2011 Feb;7(2):161-9. Epub 2011 Feb 1. Review.

PMID:
21307652
[PubMed - indexed for MEDLINE]
Free Article
16.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
[PubMed - indexed for MEDLINE]
17.

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence.

Bonanni P, Boccalini S, Bechini A.

Vaccine. 2009 May 29;27 Suppl 1:A46-53. doi: 10.1016/j.vaccine.2008.10.085. Review.

PMID:
19480962
[PubMed - indexed for MEDLINE]
18.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
[PubMed - indexed for MEDLINE]
19.

Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.

Schwarz TF.

Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Review.

PMID:
20024678
[PubMed - indexed for MEDLINE]
20.

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.

Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.

Vaccine. 2010 Nov 29;28(51):8065-72. doi: 10.1016/j.vaccine.2010.10.017. Epub 2010 Nov 16. Review.

PMID:
20971114
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk